Active — Not RecruitingNot Applicable

ANGiographic Evaluation of Left Main Coronary Artery INtErvention

Spain400 participantsStarted 2021-04-16

Plain-language summary

To assess if an angiographic follow-up at 6 months after Percutaneous Coronary Intervention in Left Main Coronary Artery Disease decrease the composite objective of death, myocardial infarction, and stroke at 36 months.

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age: 18- 85 years at the date of the PCI. * With PCI for presenting de novo lesions in the Left Main Artery by implanting a cobalt-chrome stent with everolimus-eluting fluoropolymer. * Informed consent signed. Exclusion Criteria: * Refusal to participate in the study. * Patients with left main disease who have been admitted with STEMI and have undergone primary angioplasty in a culprit lesion different than the left main. The left main lesion has been treated as a stage procedure and discharged with left ventricular ejection fraction \< 35 %. * Previous coronary surgery. * Creatinine clearance \<40 ml / min. * Contraindication for double antiaggregation after PCI. * Patients life expectancy \<36 months. * Included in other studies or clinical trials. * Pregnant or lactating women.

What they're measuring

Composite endpoint: defined as : death, myocardial infarction, and stroke.

Timeframe: 36 months

Trial details

NCT IDNCT04604197

SponsorFundación EPIC

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-03-01

View on ClinicalTrials.gov More Coronary Occlusion trials